02 Oct 2020
*A corporate client of Hybridan LLP
Dish of the day
Guild Esports GILD.L a UK-based owner and developer of esports teams. its founding shareholders include David Beckham, former football player and captain of England, and now co-owner of new MLS team Inter Miami CF. Raised £20m. Mkt cap £41.2m. Main market (standard).
Off the menu
No Leavers Today
What’s cooking in the IPO kitchen?
AIM Schedule One from Fonix, a mobile payments and messaging company, enabling businesses to charge users’ mobile bills and send users SMSs via their Carrier. Due October. Offer TBC
China Yangtze Power Co, intended secondary GDR offer on the LSE (standard listing) from the largest hydropower company in the world. Due on or around 30 September
Kaspi.kz, which operates the Kaspi.kz Super App, Kazakhstan’s most popular mobile app and the gateway to its market leading Payments, Marketplace and Fintech platforms intends to conduct a secondary GDR offer on the LSE.
Trupatti Graphite, the fully-integrated, cash generative, specialist graphite and graphene producer with operations in Madagascar and India, announced its potential intention to undertake an initial public offering on the LSE (standard listing).
Buffetology Smaller Companies Investment Trust— Buffettology is seeking to raise a minimum of £100m via an initial placing, an offer for subscription and an intermediaries offer on the Main Market. will be the Investment Manager to the Company, led by Keith Ashworth-Lord (CIO of Sanford Deland Asset Management Limited). Sanford DeLand manages approximately £1.4 billion across two open ended funds, the CFP SDL UK Buffettology Fund and the Free Spirit® Fund.
AB Ignitis grupe—leading utility and renewable energy company in the Baltic region. Admission of its Shares to the Main Trading List of Nasdaq Vilnius and admission of its GDRs to the Official List of the FCA. Offer Price Range corresponds to a market capitalisation of approximately EUR1,691.7 – EUR2,105.2m. Due 7 Oct.
Calnex, an established provider of test and measurement solutions for the global telecommunications sector, will raise a total of £22.5m (before expenses), comprising £6.0m for the Company and £16.5m for existing shareholders . Due 5 October 2020, under the ticker CLX. Based on the Placing Price, the market capitalisation of the Company will be £42.0m on Admission.
Mode Global Holdings to join LSE (standard). Mode is a UK-based Fintech Group, building a modern financial services business to support an increasingly digitised economy and financial system, combining the best of banking, payments, investment, loyalty and digital assets. Targeting £7.5m raise.
HOME REIT intends to float to the Main Market raising up to £250m. The Company will seek to contribute to the alleviation of homelessness in the UK, whilst targeting inflation-protected income and capital returns, by investing in a diversified portfolio of assets across the UK which will be dedicated to providing accommodation to the homeless. Due Mid October
Umuthi Healthcare Solutions Plc, the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas, seeking admission to the Standard Listing segment of the Official List
Kibo Energy PLC, the multi-asset Africa focused energy company, is seeking admission for its 100% owned UK subsidiary Sloane Developments Ltd , which will be renamed Mast Energy Developments PLC (MED), to the Standard List of the London Stock Exchange plc . Targeted for Q4 2020. The MED business strategy is to acquire and develop a portfolio of flexible small-scale power generation assets, exploiting a growth niche market in the UK for Reserve Power generation to balance out the national grid at critical times.
Bahamas Petroleum 2.22p £73.4m (LON:BPC)
The Caribbean and Atlantic margin focused oil and gas company, with exploration, production, appraisal and development assets across the region, advises of the current status of two contract arrangements in Trinidad & Tobago.
The term of the current Goudron Incremental Production Service Contract (“IPSC”) with Heritage Petroleum Company Limited has been extended from 30 September 2020 until 31 December 2020. This extension of term is an interim measure to allow time for Heritage to obtain requisite consents from the Ministry of Energy and Energy Industries for the implementation of a new 10-year Enhanced Production Sharing Contract (“EPSC”) agreement.
In relation to BPC’s Inniss-Trinity asset, in accordance with the Well Participation Agreement (“WPA”) entered into in November 2017 with Predator Oil & Gas Holding Limited, by 30 September 2020 Predator was required to enter into a share purchase agreement (“SPA”) under which Predator would acquire the corporate entity that holds 100% of the Inniss-Trinity asset, for a consideration of US$4.25 million. The Company advises that BPC and Predator have not entered into such an SPA by the agreed deadline, and accordingly, this aspect of the WPA has lapsed.
Arcontech Group 163.5p £21.7m (LON:ARC)
The provider of products and services for real-time financial market data processing and trading, announced the signing of a new Tier 1 bank client for its MVCS (Multi-Vendor Contribution System), which enables those that create market data content, whether real-time instrument prices, auction results or policy statements, to be contributed to multiple vendors and internal consumers at the same time. Although anticipated revenues are not expected to be material initially, it is the start of an important relationship with a Tier 1 global institution
Discussions commenced as the bank wished to contribute real-time prices to Factset where the bank’s clients wanted to view them and for which their existing market-data infrastructure provider was unable to help.
Van Elle Hldgs 35p £37.3m (LON:VANL)
The UK’s largest ground engineering contractor, has entered into an agreement with ABN AMRO Commercial Finance, for up to £11m of asset-based lending facilities. The Facilities are provided on a revolving basis over 4 years and are secured by an all assets debenture including first priority charges over the Group’s receivables and certain tangible fixed assets. There are no financial covenants associated with the Facilities.
The new Facilities, which shall be undrawn on completion, provide additional balance sheet strength to enable the Group to support growth and provides greater flexibility for future capital expenditure requirements. The Group’s cash position at the end of September was c.£11.5m and the remaining debt under hire purchase agreements is £5.7m. With net funds (excluding IFRS 16 property lease liabilities) of c.£5.8m, the Group is well-positioned to face any short-term market challenges. As part of the refinancing, the existing overdraft facility with Lloyds Banking Group of £2.5m has been terminated.
Scancell Hldgs 17.9p £112.5m (LON:SCLP)
Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO manufacturer of biological materials and pharmaceuticals, and Scancell Holdings PLC (Scancell), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announced that they have entered into a collaboration for Cobra to manufacture Scancell’s COVID-19 vaccine. The agreement covers Good Manufacturing Practice (GMP) production of plasmid DNA needed to generate the DNA vaccine, against SARS-CoV-2, for use in a Phase 1 clinical trial in 2021 (COVIDITY). The project is funded by an Innovate UK grant awarded to the consortium between Scancell, the University of Nottingham and Trent University, as previously announced in August 2020.
Update on its investment in Sure Valley Ventures (“SVV”) in relation to Ambisense, a company within the SVV portfolio, which provides sensors and an analysis platform to allow real-time gas and environmental monitoring.
Ambisense has announced its entry into the air quality market with the launch of AmbiAir, a solution designed to help manage, assess, and predict the COVID-19 risk in commercial and public buildings .
By increasing building ventilation, and combining it with measures such as social distancing, it is possible to decrease the COVID-19 risk in public spaces. Studies show that the danger of exposure to COVID-19 is reduced when the level of CO2 is below 600ppm, relative humidity is between 40-60%, and there are no or very minimal levels of PM2.5.
Draper Esprit 586p £699m (LON:GROW)
The venture capital firm investing in and developing high growth digital technology businesses across Europe, announced that, further to the announcement made yesterday, it has secured funding commitments to raise gross proceeds of £110 million at a placing price of 555 pence per share. The Company believes there is a significant opportunity to deploy further capital driven by a growing European venture capital market and an accelerated transition to digital driven by the COVID-19 pandemic.
The integrated communications company that provides unified communications and contact centre software that tightly integrates with Customer Relationship Management (“CRM”) platforms, announces it has a new integration with Eclipse Software.
Eclipse Software, client and candidate management system, is based in the UK with 6000 users globally, adds CloudCall’s productivity enhancing tools and intelligent dialling capabilities to their existing portfolio of services. The integration with Eclipse has already seen a customer win with TXM in the UK and Australia, resulting in more than 130 new users.
The Boards of Holders Technology and Senson BV (holding company of Sentistic BV) announced the creation of a 50:50 joint venture between the two companies to be known as Holders Technology Data Analytics Ltd. (“HTDA”).
This exciting new joint venture combines the technical sales resources of Holders Technology Lighting and Controls Divisions with the data analytics expertise of Sentistic BV (www.sentistic.com). HTDA will provide data visualisation and valuable insights based on data from buildings using the Casambi wireless lighting control system, as well as data from other third party sources. Clients will also be able to integrate data from the Holders Analytics solution into their existing building management systems.
Abbey 1475p £308m (LON:ABBY)
Trading update. Trading over the Summer has been good. In Southern England sales have been buoyed by the cut in Stamp Duty together with the UK Governments ‘Help to Buy’ programme. In Ireland sales activity is running ahead of last year and interest in our future developments has been stimulated by the Government’s support for first time buyers. The Group is currently on track to match or perhaps better last year’s first half turnover and profit.
For the year as a whole the outlook is less clear with the significant restriction of the UK ‘Help to Buy’ programme together with the increase to stamp duty planned for April next year particular sources of uncertainty. Overall the Group is hoping for a satisfactory full year outcome. The company’s main activities are residential housing development in the United Kingdom, Ireland and Prague.
Falcon Oil 7.85p £77m (LON:FOG)
Technical update on the Beetaloo project in the Beetaloo Sub-basin, Northern Territory, Australia regarding the hydraulic stimulation of the horizontal Kyalla 117 N2-1H ST2 well (“Kyalla 117 well”).
Completion of 11 hydraulic stimulation stages along the 1,579-metre horizontal section in the Lower Kyalla Formation
Stimulation treatments were successfully executed
Activities have commenced in preparation for the flowback and extended production test
Early stage gas flow rates are expected in the coming weeks
Philip O’Quigley (CEO of Falcon) commented:
“We look forward to the next phase of operations with the production testing of the Kyalla 117 well and will update the market as results become available.”
0203 764 2344
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of section B of annex I to Directive 2014/65/EU (“MIFID II Directive”); or (ii) investment research as defined in article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.